Biotech Startup Pandorum Bags $18 Mn To Develop Therapies For Rare Ocular Diseases

Biotechnology firm Pandorum Technologies has raised $18 million (Rs 163 crore) in a Series B round to advance the clinical development of its therapies that target diseases on the surface of the eye.The Bengaluru-based startup, which operates research facilities in India and the US, said Monday the round was led by Vapi, Gujarat-based Protons Corporate Services Pvt Ltd.Drugmaker Galentic Pharma, stock market investor Ashish Kacholia, Noblevast Advisory, early-stage venture capital firm Avinya Ventures, and the Burman family were among the other investors that joined the round.